These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26268355)

  • 21. Detection of hepatitis B virus variants in HBV monoinfected and HBV/HIV coinfected Iranian patients under lamivudine treatment.
    Aghasadeghi MR; Bahramali G; Sadat SM; Farahani A; Mohraz M; Davar Siadat S; Mostafavi E; Memarnejadian A; Ardestani MS; Vahabpour R; Saraji AA; Delbaz SA
    Curr HIV Res; 2011 Jun; 9(4):263-9. PubMed ID: 21671883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients.
    Coffin CS; Osiowy C; Myers RP; Gill MJ
    J Clin Virol; 2013 Jun; 57(2):103-8. PubMed ID: 23465393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.
    Bihl F; Martinetti G; Wandeler G; Weber R; Ledergeber B; Calmy A; Battegay M; Cavassini M; Vernazza P; Caminada AP; Rickenbach M; Bernasconi E;
    BMC Gastroenterol; 2015 Jul; 15():79. PubMed ID: 26152237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
    Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
    Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection.
    Iroezindu MO; Agbaji OO; Daniyam CA; Isiguzo GC; Isichei C; Akanbi MO
    Int J STD AIDS; 2013 Jun; 24(6):461-7. PubMed ID: 23970749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of drug resistance mutations in the HBV genome in ART-experienced HIV-coinfected patients in southwestern Nigeria.
    Akanbi OA; Harms D; Wang B; Osundare FA; Adesina O; Oluremi AS; Omoruyi EC; Kappert K; Opaleye OO; Bock CT
    Antivir Ther; 2019; 24(7):521-528. PubMed ID: 31566576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon.
    Bivigou-Mboumba B; François-Souquière S; Deleplancque L; Sica J; Mouinga-Ondémé A; Amougou-Atsama M; Chaix ML; Njouom R; Rouet F
    PLoS One; 2016; 11(1):e0143869. PubMed ID: 26764909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Widespread hepatitis B virus genotype G (HBV-G) infection during the early years of the HIV epidemic in the Netherlands among men who have sex with men.
    Cornelissen M; Zorgdrager F; Bruisten SM; Bakker M; Berkhout B; van der Kuyl AC
    BMC Infect Dis; 2016 Jun; 16():268. PubMed ID: 27286832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.
    Anggorowati N; Yano Y; Heriyanto DS; Rinonce HT; Utsumi T; Mulya DP; Subronto YW; Hayashi Y
    J Med Virol; 2012 Jun; 84(6):857-65. PubMed ID: 22499006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire.
    Boyd A; Moh R; Gabillard D; le Carrou J; Danel C; Anglaret X; Eholié SP; Maylin S; Delaugerre C; Zoulim F; Girard PM; Lacombe K;
    Antivir Ther; 2015; 20(6):643-54. PubMed ID: 25852125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phylogenetic and drug- and vaccine-resistance profiles of Hepatitis B Virus among children with HIV co-infection in Pakistan.
    Farooqui N; Mir F; Siddiqui D; Hotwani A; Nathwani AA; Mahmood SF; Sadiq K; Kayani HA; Sheikh SA; Shah SA; Ferrand RA; Abidi SH
    Infect Genet Evol; 2022 Nov; 105():105371. PubMed ID: 36179949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patients.
    Lacombe K; Boyd A; Lavocat F; Pichoud C; Gozlan J; Miailhes P; Lascoux-Combe C; Vernet G; Girard PM; Zoulim F
    Hepatology; 2013 Sep; 58(3):912-22. PubMed ID: 23468093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
    Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
    Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in Botswana.
    Phinius BB; Anderson M; Gobe I; Mokomane M; Choga WT; Phakedi B; Ratsoma T; Mpebe G; Makhema J; Shapiro R; Lockman S; Musonda R; Moyo S; Gaseitsiwe S
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon.
    Kouanfack C; Aghokeng AF; Mondain AM; Bourgeois A; Kenfack A; Mpoudi-Ngolé E; Ducos J; Delaporte E; Laurent C
    Antivir Ther; 2012; 17(2):321-6. PubMed ID: 22290198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Hepatitis Delta Virus Infection on the Selection of Hepatitis B Surface Antigen Mutations.
    Baruti K; Choga WT; Phinius BB; Phakedi B; Bhebhe L; Mpebe GGA; Motshosi PC; Ratsoma T; Moyo S; Jongman M; Anderson M; Gaseitsiwe S
    Genes (Basel); 2024 Jul; 15(8):. PubMed ID: 39202343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations.
    Audsley J; Arrifin N; Yuen LK; Ayres A; Crowe SM; Bartholomeusz A; Locarnini SA; Mijch A; Lewin SR; Sasadeusz J
    HIV Med; 2009 Apr; 10(4):229-35. PubMed ID: 19178592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
    Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
    J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The variability of hepatitis B envelope is associated with HBs antigen persistence in either chronic or acute HBV genotype A infection.
    Eschlimann M; Malvé B; Velay A; Fenaux H; Berger S; Frippiat JP; Zoulim F; Bensenane M; Bronowicki JP; Goehringer F; May T; Jeulin H; Schvoerer E
    J Clin Virol; 2017 Sep; 94():115-122. PubMed ID: 28822954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.